BBWI241129P50000
- 0.00
- 0.000.00%
Bath & Body Works Newsroom
Telsey Advisory Maintains Bath & Body Works(BBWI.US) With Buy Rating, Raises Target Price to $43
Barclays Maintains Underweight on Bath & Body Works, Raises Price Target to $34
Morgan Stanley Maintains Bath & Body Works(BBWI.US) With Buy Rating, Maintains Target Price $49
Bath & Body Works Is Maintained at Neutral by Piper Sandler
A Quick Look at Today's Ratings for Bath & Body Works(BBWI.US), With a Forecast Between $34 to $52
Hold Rating for Bath & Body Works Amid Revenue Growth and Margin Concerns
Bath & Body Works: Strong Growth Prospects and Strategic Innovation Drive Buy Rating
Telsey Advisory Group Maintains Outperform on Bath & Body Works, Maintains $42 Price Target
Bath & Body Works Analyst Ratings
Best Buy, Zoom, CrowdStrike, Macy's, and More Stocks to Watch This Week -- Barrons.com
J.P. Morgan Maintains Bath & Body Works(BBWI.US) With Hold Rating, Announces Target Price $35
Citi Maintains Bath & Body Works(BBWI.US) With Hold Rating, Maintains Target Price $35
Analysts Conflicted on These Consumer Cyclical Names: Lucid Group (LCID), Global-e Online (GLBE) and Bath & Body Works (BBWI)
Bath & Body Works Is Maintained at Outperform by Telsey Advisory Group
Bath & Body Works Analyst Ratings
Morgan Stanley Maintains Bath & Body Works(BBWI.US) With Buy Rating, Cuts Target Price to $48
Morgan Stanley Adjusts Price Target on Bath & Body Works to $48 From $51, Maintains Overweight Rating
Barclays Downgrades Bath & Body Works(BBWI.US) to Sell Rating, Cuts Target Price to $28
Bath & Body Works Analyst Ratings
Wells Fargo Maintains Bath & Body Works(BBWI.US) With Hold Rating, Cuts Target Price to $32